Postoperative Radiation Field for Buccal Mucosa Carcinoma
The postoperative radiation field for buccal mucosa carcinoma should include the tumor bed and involved, dissected lymph node regions, with dose escalation to areas of positive margins or extracapsular extension.
Target Volume Components
High-Risk Sites (60-66 Gy)
Regions requiring the highest dose include:
- Tumor bed with adequate margins
- Areas of microscopically positive surgical margins (60-66 Gy at 2 Gy/fraction) 1
- Regions with extracapsular nodal extension (60-66 Gy at 2 Gy/fraction) 1
The evidence from ASCO/ASTRO guidelines, though focused on oropharyngeal cancer, provides the framework for postoperative head and neck radiation that applies to oral cavity subsites including buccal mucosa 1.
Standard-Risk Sites (56-60 Gy)
In the absence of positive margins or extracapsular extension:
Elective Nodal Sites (44-63 Gy)
Sites of suspected subclinical spread require:
- 44-50 Gy for 3D conformal RT
- 54-63 Gy (1.6-1.8 Gy/fraction) for IMRT 2
Laterality Considerations
For well-lateralized buccal mucosa carcinoma with no contralateral nodal involvement, ipsilateral neck radiation is sufficient. Research specifically addressing buccal mucosa demonstrates no contralateral neck failures with unilateral treatment in properly selected cases 3. This approach facilitates better sparing of contralateral organs at risk without compromising disease control 3, 4.
Bilateral neck irradiation is indicated when:
- Tumor crosses midline
- Contralateral nodal involvement present
- Extensive soft palate or tongue base extension
Critical Pathologic Risk Factors
Dose escalation to 60-66 Gy is mandatory for:
- Positive surgical margins (tumor ≤1 mm from margin) 5, 6, 7
- Extracapsular nodal extension 5
- Close margins (1-5 mm) - consider higher doses 5
Standard dose (56-60 Gy) with consideration for concurrent chemotherapy for:
- pT3-T4 disease 1, 5
- Multiple positive nodes (>1) 5
- Perineural invasion 5
- Lymphovascular invasion 5
- Bone invasion 7
Research specific to buccal mucosa confirms that postoperative radiotherapy significantly improves disease-free survival in locally advanced cases (68% vs 38% at 3 years, p<0.005) 8, with particular benefit for close surgical margins 7.
Timing Considerations
Critical timing requirement: Start radiation within 6 weeks of surgery, ideally completing the entire treatment course within 85 days 1. For buccal mucosa specifically, local failure rates increase significantly when the interval between surgery and radiotherapy exceeds 30 days 7. This timing factor may be more important than dose per se in single-modality postoperative radiotherapy 1.
Technical Approach
For early-stage, well-lateralized buccal mucosa:
- 3D conformal RT is adequate and preferred over IMRT 4
- Provides excellent target coverage with better sparing of contralateral salivary glands 4
The "T-N tract" concept: Include the lymphatic pathway between the primary tumor site and neck nodes, encompassing the platysma muscle and facial vessel plane 9. This compartmental approach addresses the lack of anatomical barriers in the buccal region.
Common Pitfalls
- Insufficient dose to positive margins: Standard 60 Gy may be inadequate; consider 66 Gy or concurrent chemotherapy 6
- Delayed radiation start: Each week of delay beyond 6 weeks compromises outcomes 7
- Unnecessary bilateral treatment: Increases toxicity without benefit in well-lateralized disease 3
- Inadequate coverage of tumor bed: Must include adequate margins around the surgical cavity